Background
Early detection of MRSA in clinical specimens is imperative to prevent cross transmission, morbidity, mortality and overall cost of treatment. Additionally, rapid detection of MRSA helps in preventing superficial skin infection to become deep seated.
Method
Fifty isolates of MRSA from different specimens like blood, urine, exudates and respiratory were collected from 2010 to 2011. MRSA screen slide latex agglutination test kit (Denka Seikan, Japan) was used for PBP2′ detection and Oxacillin Resistant Screen Agar Base (ORSAB) with supplement (Oxoid Ltd., UK) was used for detection of MRSA from the isolates with ATCC controls. The detection of mecA gene in the MRSA isolates was considered as the reference method for determining the sensitivity of each phenotype rapid method studied.
Results
All the 50 isolates of MRSA were positive for mecA by PCR. MRSA screen for PBP2′ detection and ORSAB had a sensitivity of 93.75% and 95.8%, respectively. Chi square statistical analysis was carried out for the comparison of the rapid methods. Chi square value was found to be 3.0928 (p value=0.07864) and 2.0408 (p value =0.153127) at 5% level of significance. OR (Odds ratio) =7.4421 (95%CI=0.3744–147.9331) and OR=5.2062 (95%CI=0.2436–111.2444), respectively.
Conclusion
In the present study, we found that the difference in sensitivity between PCR for mecA and the phenotype rapid methods is statistically not significant. Therefore, we conclude that phenotype rapid methods can be used for the detection of MRSA from clinical isolates in low resource health care settings.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.